BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 27, 2026
Home » Topics » Analysis and data insight, Medical technology

Analysis and data insight, Medical technology
Analysis and data insight, Medical technology RSS Feed RSS

Med-tech gainers and losers for Dec. 18-22, 2023

Dec. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Dec. 11-15, 2023

Dec. 18, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
medtech deals
Med-tech deals November 2023

November sees $441M in deals, cumulative value up 34% YOY

Dec. 15, 2023
By Amanda Lanier

Total med-tech deal value through November is up 34.42% over the same period last year and is also higher than every comparable period from 2019-2022. Conversely, med-tech M&A value experienced a decline of 64.07% compared to the first 11 months of 2022.


Read More
Dollar symbol with arrow graph

Med-tech gainers and losers for Dec. 4-8, 2023

Dec. 11, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Stock chart, red down arrow
Med-tech financings November 2023

Med-tech financings mark YOY decline, November sees more than $1B raised

Dec. 8, 2023
By Amanda Lanier
Med-tech financings surpassed $1 billion again in November, with transactions totalling $1.02 billion for the month. Though a decline from the $1.23 billion raised in October, the value is up from September’s $645.75 million.
Read More

Med-tech gainers and losers for Nov. 27-Dec. 1, 2023

Dec. 4, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 20-24, 2023

Nov. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 13-17, 2023

Nov. 20, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 6-10, 2023

Nov. 13, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech deals October 2023

Med-tech M&As continue decline while deal value soars nearly 50% YOY

Nov. 10, 2023
By Amanda Lanier
While med-tech deals were well below average the past two months, cumulative values are up 47.67% over the same period last year. Through October, the total worth of med-tech deals reached $9.97 billion, rising from $6.75 billion in the corresponding period in 2022.
Read More
Previous 1 2 … 20 21 22 23 24 25 26 27 28 … 55 56 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 27, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 26, 2026
  • Microscopy of a cross-section of mouse skin containing melanoma tumors

    Researchers identify innate immune barrier against melanoma

    BioWorld
    Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
  • In the clinic for May 26, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
  • Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

    BioWorld Science
    Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing